本页面由Tiger Trade Technology Pte. Ltd.提供服务

再鼎医药

24.82
-0.1700-0.68%
成交量:30.14万
成交额:748.11万
市值:27.89亿
市盈率:-14.57
高:25.00
开:24.88
低:24.51
收:24.99
52周最高:32.76
52周最低:15.96
股本:1.12亿
流通股本:9,711.04万
量比:0.50
换手率:0.31%
股息:- -
股息率:- -
每股收益(TTM):-1.7030
每股收益(LYR):-1.6026
净资产收益率:-26.91%
总资产收益率:-14.75%
市净率:4.59
市盈率(LYR):-15.49

数据加载中...

2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/06

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities